1 unchanged sentence
Incorporated by reference herein
−Removed: Pacific Biosciences of California, Inc.
−Removed: 2020 Inducement Equity Incentive Plan, as amended, and forms of agreement thereunder
−Removed: November 19, 2021
−Removed: Change in Control and Severance Agreement, by and between the Registrant and Denis Zaccarin, Ph.D.
−Removed: effective November 4, 2020
+Added: Amended and Restated Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated June 24, 2022
Filed herewith
−Removed: Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc.
−Removed: and related forms of agreement thereunder
−Removed: November 5, 2021
+Added: Pacific Biosciences of California, Inc.
+Added: 2020 Equity Incentive Plan, as amended
+Added: Form of Global Stock Option Agreement under the Pacific Biosciences of California, Inc.
+Added: 2020 Equity Incentive Plan, as amended
+Added: Form of Global Restricted Stock Unit Agreement under the Pacific Biosciences of California, Inc.
+Added: 2020 Equity Incentive Plan, as amended
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
10 unchanged sentences
Filed herewith
−Removed: XBRL Taxonomy Extension Schema Document
+Added: Inline XBRL Taxonomy Extension Schema Document
Filed herewith
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
Filed herewith
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document
Filed herewith
−Removed: XBRL Taxonomy Extension Labels Linkbase Document
+Added: Inline XBRL Taxonomy Extension Labels Linkbase Document
Filed herewith
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document
Filed herewith
1 unchanged sentence
Filed herewith
+Added: Confidential portions of this exhibit have been omitted in accordance with Item 601(b)(10) of Regulation S-K because they are private, confidential and not material, and will be supplementally furnished to the SEC upon request.
+ Indicates management contract or compensatory plan.
−Removed: * The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Pacific Biosciences of California, Inc.
+Added: * The certification s att ached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Pacific Biosciences of California, Inc.
under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
1 unchanged sentence
Pacific Biosciences of California, Inc.
+Added: August 5, 2022
/s/ Christian O.
1 unchanged sentence
(Principal Executive Officer)
−Removed: /s/ S USAN G.
+Added: August 5, 2022
Chief Financial Officer
(Principal Financial Officer)
+Added: August 5, 2022
/s/ Michele Farmer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.